
Analyst Insights
SAB Biotherapeutics Inc (SABS) EPS growth this year is 43.75%: Get Prepared for Trading Lift Off
As on Thursday, SAB Biotherapeutics Inc (NASDAQ: SABS) got off with the flyer as it spiked 4.42% to $2.6, before settling in for the price